No Data
No Data
Earnings Preview: VRTX to Report Financial Results Post-market on May 05
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Vertex Pharmaceuticals Hits 4-week High
Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating
Express News | The European Medicines Agency's Committee For Medicinal Products For Human Use Adopted A Positive Opinion For Vertex Pharmaceuticals' Alyftrek (Deutivacaftor/Tezacaftor/Vanzacaftor) For Cystic Fibrosis Patients Aged 6 Years And Older Who Have At Least...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)